Product Information

TIMOLOL 0.25% GEL-SOLUTION is a generic product labeled by Bausch & Lomb Americas Inc., priced at $6.7078 per ML under NDC 82260081825. Its NADAC has been published 136 times since Apr 17, 2024.

FDA first approved this application on Nov 4, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Timolol Maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TIMOLOL 0.25% GEL-SOLUTION

Timolol Maleate
$6.7078per ML
High Outlier

Strength

2.5 mg/mL

NDC

82260081825

Classification

Generic

Dosage Form

SOLUTION

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

TIMOLOL MALEATE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA020330

FDA Approved

11/4/1993

TE Code

AB

On Market Since

2/14/2018

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for TIMOLOL 0.25% GEL-SOLUTION has been published 136 times since Apr 17, 2024, and over the history we have for it it has declined 79.2%. The table below summarizes its recorded NADAC range and movement.

Current price$6.7078 per ML
All-time high$32.2814 (May 15, 2024)
All-time low$6.2884 (Oct 21, 2026)
52-week high$18.7032
52-week low$6.2884
Median price$18.6502
Average price$18.0678
Largest weekly change-30.7% (May 22, 2024)
Weeks tracked136
Tracking sinceApr 17, 2024

Price History

1W

+6.7%

1M

+5.2%

3M

-4.0%

6M

-48.4%

1Y

-63.6%

3Y

N/A

5Y

N/A

All

-79.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 91% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 91%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TIMOLOL 0.25% GEL-SOLUTION?

The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL 0.25% GEL-SOLUTION, manufactured by Bausch & Lomb Americas Inc., is $6.7078 per ML (NDC 82260081825), effective Nov 18, 2026.

How has the price of TIMOLOL 0.25% GEL-SOLUTION changed over time?

Over the history we have for it, the NADAC for TIMOLOL 0.25% GEL-SOLUTION has declined 79.2%. It has been tracked across 136 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for TIMOLOL 0.25% GEL-SOLUTION?

Since Apr 17, 2024, the NADAC for TIMOLOL 0.25% GEL-SOLUTION has ranged from a low of $6.2884 (Oct 21, 2026) to a high of $32.2814 (May 15, 2024), with a median of $18.6502 per ML.

Are there cheaper alternatives to TIMOLOL 0.25% GEL-SOLUTION?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TIMOLOL MALEATE 0.25% EYE DROP, is $0.6031 per ML — about 91% below TIMOLOL 0.25% GEL-SOLUTION.

Who manufactures TIMOLOL 0.25% GEL-SOLUTION?

TIMOLOL 0.25% GEL-SOLUTION (NDC 82260081825) is labeled by Bausch & Lomb Americas Inc., and CMS classifies it as a generic product.